Antibody-drug conjugates (ADCs) represent a revolutionary advancement in the struggle against cancer. ADCs fuse the specificity of antibodies with the potent power of cytotoxic drugs. By delivering these potent agents directly to malignant tissues , ADCs enhance treatment efficacy while reducing harm to healthy organs. This directed approach holds